Connection

Gustavo Leone to Female

Back to Details
This is a "connection" page, showing publications Gustavo Leone has written about Female.
Gustavo Leone
Connection Strength
0.659
Female
  1. Evaluating the efficacy of enzalutamide and the development of resistance in a preclinical mouse model of type-I endometrial carcinoma. Neoplasia. 2020 10; 22(10):484-496.
    View in: PubMed
    Score: 0.038
  2. Two Distinct E2F Transcriptional Modules Drive Cell Cycles and Differentiation. Cell Rep. 2019 06 18; 27(12):3547-3560.e5.
    View in: PubMed
    Score: 0.035
  3. Endoreduplication of the mouse genome in the absence of ORC1. Genes Dev. 2018 07 01; 32(13-14):978-990.
    View in: PubMed
    Score: 0.033
  4. Discovery of Stromal Regulatory Networks that Suppress Ras-Sensitized Epithelial Cell Proliferation. Dev Cell. 2017 05 22; 41(4):392-407.e6.
    View in: PubMed
    Score: 0.030
  5. E2f8 mediates tumor suppression in postnatal liver development. J Clin Invest. 2016 08 01; 126(8):2955-69.
    View in: PubMed
    Score: 0.029
  6. E2f3 in tumor macrophages promotes lung metastasis. Oncogene. 2016 07 14; 35(28):3636-46.
    View in: PubMed
    Score: 0.027
  7. Noncatalytic PTEN missense mutation predisposes to organ-selective cancer development in vivo. Genes Dev. 2015 Aug 15; 29(16):1707-20.
    View in: PubMed
    Score: 0.027
  8. Redeployment of Myc and E2f1-3 drives Rb-deficient cell cycles. Nat Cell Biol. 2015 Aug; 17(8):1036-48.
    View in: PubMed
    Score: 0.027
  9. Selective roles of E2Fs for ErbB2- and Myc-mediated mammary tumorigenesis. Oncogene. 2015 Jan 02; 34(1):119-28.
    View in: PubMed
    Score: 0.024
  10. Canonical and atypical E2Fs regulate the mammalian endocycle. Nat Cell Biol. 2012 Nov; 14(11):1192-202.
    View in: PubMed
    Score: 0.022
  11. Atypical E2F repressors and activators coordinate placental development. Dev Cell. 2012 Apr 17; 22(4):849-62.
    View in: PubMed
    Score: 0.021
  12. E2f1-3 switch from activators in progenitor cells to repressors in differentiating cells. Nature. 2009 Dec 17; 462(7275):930-4.
    View in: PubMed
    Score: 0.018
  13. E2f3a and E2f3b contribute to the control of cell proliferation and mouse development. Mol Cell Biol. 2009 Jan; 29(2):414-24.
    View in: PubMed
    Score: 0.017
  14. Direct evidence for epithelial-mesenchymal transitions in breast cancer. Cancer Res. 2008 Feb 01; 68(3):937-45.
    View in: PubMed
    Score: 0.016
  15. Extra-embryonic function of Rb is essential for embryonic development and viability. Nature. 2003 Feb 27; 421(6926):942-7.
    View in: PubMed
    Score: 0.011
  16. Discovery of nonautonomous modulators of activated Ras. G3 (Bethesda). 2022 09 30; 12(10).
    View in: PubMed
    Score: 0.011
  17. Origin, activation and heterogeneity of fibroblasts associated with pancreas and breast cancers. Adv Cancer Res. 2022; 154:169-201.
    View in: PubMed
    Score: 0.011
  18. Non-phosphorylatable cyclin D1 mutant potentiates endometrial hyperplasia and drives carcinoma with Pten loss. Oncogene. 2022 04; 41(15):2187-2195.
    View in: PubMed
    Score: 0.010
  19. RNA-binding protein FXR1 drives cMYC translation by recruiting eIF4F complex to the translation start site. Cell Rep. 2021 11 02; 37(5):109934.
    View in: PubMed
    Score: 0.010
  20. Protein Phosphatase 2A Activation Via ApoER2 in Trophoblasts Drives Preeclampsia in a Mouse Model of the Antiphospholipid Syndrome. Circ Res. 2021 09 17; 129(7):735-750.
    View in: PubMed
    Score: 0.010
  21. Nuclear PFKP promotes CXCR4-dependent infiltration by T cell acute lymphoblastic leukemia. J Clin Invest. 2021 08 16; 131(16).
    View in: PubMed
    Score: 0.010
  22. T-cell apoptosis induced by granulocyte colony-stimulating factor is associated with retinoblastoma protein phosphorylation and reduced expression of cyclin-dependent kinase inhibitors. Exp Hematol. 2001 Apr; 29(4):401-15.
    View in: PubMed
    Score: 0.010
  23. Modeling Human Cancer-induced Cachexia. Cell Rep. 2019 08 06; 28(6):1612-1622.e4.
    View in: PubMed
    Score: 0.009
  24. Abrupt involution induces inflammation, estrogenic signaling, and hyperplasia linking lack of breastfeeding with increased risk of breast cancer. Breast Cancer Res. 2019 07 17; 21(1):80.
    View in: PubMed
    Score: 0.009
  25. Sex-specific regulation of stress-induced fetal glucocorticoid surge by the mouse placenta. Am J Physiol Endocrinol Metab. 2019 07 01; 317(1):E109-E120.
    View in: PubMed
    Score: 0.009
  26. Stromal PTEN determines mammary epithelial response to radiotherapy. Nat Commun. 2018 07 17; 9(1):2783.
    View in: PubMed
    Score: 0.008
  27. Crosstalk between PKCa and PI3K/AKT Signaling Is Tumor Suppressive in the Endometrium. Cell Rep. 2018 07 17; 24(3):655-669.
    View in: PubMed
    Score: 0.008
  28. Fibroblast-derived CXCL12 promotes breast cancer metastasis by facilitating tumor cell intravasation. Oncogene. 2018 08; 37(32):4428-4442.
    View in: PubMed
    Score: 0.008
  29. A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer. Breast Cancer Res Treat. 2018 Jun; 169(3):457-467.
    View in: PubMed
    Score: 0.008
  30. hsa-mir183/EGR1-mediated regulation of E2F1 is required for CML stem/progenitor cell survival. Blood. 2018 04 05; 131(14):1532-1544.
    View in: PubMed
    Score: 0.008
  31. Generation of a pancreatic cancer model using a Pdx1-Flp recombinase knock-in allele. PLoS One. 2017; 12(9):e0184984.
    View in: PubMed
    Score: 0.008
  32. NF-?B regulates GDF-15 to suppress macrophage surveillance during early tumor development. J Clin Invest. 2017 Oct 02; 127(10):3796-3809.
    View in: PubMed
    Score: 0.008
  33. Stromal PDGFR-a Activation Enhances Matrix Stiffness, Impedes Mammary Ductal Development, and Accelerates Tumor Growth. Neoplasia. 2017 Jun; 19(6):496-508.
    View in: PubMed
    Score: 0.008
  34. Stromal PTEN inhibits the expansion of mammary epithelial stem cells through Jagged-1. Oncogene. 2017 04 20; 36(16):2297-2308.
    View in: PubMed
    Score: 0.007
  35. RB1 deficiency in triple-negative breast cancer induces mitochondrial protein translation. J Clin Invest. 2016 10 03; 126(10):3739-3757.
    View in: PubMed
    Score: 0.007
  36. Effect of all-trans retinoic acid on procoagulant and fibrinolytic activities of cultured blast cells from patients with acute promyelocytic leukemia. Blood. 1995 Nov 01; 86(9):3535-41.
    View in: PubMed
    Score: 0.007
  37. CSF1-ETS2-induced microRNA in myeloid cells promote metastatic tumor growth. Oncogene. 2015 Jul; 34(28):3651-61.
    View in: PubMed
    Score: 0.006
  38. Cited2 is required in trophoblasts for correct placental capillary patterning. Dev Biol. 2014 Aug 01; 392(1):62-79.
    View in: PubMed
    Score: 0.006
  39. HO-3867, a safe STAT3 inhibitor, is selectively cytotoxic to ovarian cancer. Cancer Res. 2014 Apr 15; 74(8):2316-27.
    View in: PubMed
    Score: 0.006
  40. Stat5 regulates the phosphatidylinositol 3-kinase/Akt1 pathway during mammary gland development and tumorigenesis. Mol Cell Biol. 2014 Apr; 34(7):1363-77.
    View in: PubMed
    Score: 0.006
  41. Ets2 in tumor fibroblasts promotes angiogenesis in breast cancer. PLoS One. 2013; 8(8):e71533.
    View in: PubMed
    Score: 0.006
  42. A positive feedback loop involving Gcm1 and Fzd5 directs chorionic branching morphogenesis in the placenta. PLoS Biol. 2013; 11(4):e1001536.
    View in: PubMed
    Score: 0.006
  43. Reprogramming of the tumour microenvironment by stromal PTEN-regulated miR-320. Nat Cell Biol. 2011 Dec 18; 14(2):159-67.
    View in: PubMed
    Score: 0.005
  44. S100A7 enhances mammary tumorigenesis through upregulation of inflammatory pathways. Cancer Res. 2012 Feb 01; 72(3):604-15.
    View in: PubMed
    Score: 0.005
  45. Pten in the breast tumor microenvironment: modeling tumor-stroma coevolution. Cancer Res. 2011 Feb 15; 71(4):1203-7.
    View in: PubMed
    Score: 0.005
  46. Non-parametric population analysis of cellular phenotypes. Med Image Comput Comput Assist Interv. 2011; 14(Pt 2):343-51.
    View in: PubMed
    Score: 0.005
  47. The Ras oncogene signals centrosome amplification in mammary epithelial cells through cyclin D1/Cdk4 and Nek2. Oncogene. 2010 Sep 09; 29(36):5103-12.
    View in: PubMed
    Score: 0.005
  48. An ets2-driven transcriptional program in tumor-associated macrophages promotes tumor metastasis. Cancer Res. 2010 Feb 15; 70(4):1323-33.
    View in: PubMed
    Score: 0.005
  49. Synthetic cannabinoid receptor agonists inhibit tumor growth and metastasis of breast cancer. Mol Cancer Ther. 2009 Nov; 8(11):3117-29.
    View in: PubMed
    Score: 0.004
  50. Tensor classification of N-point correlation function features for histology tissue segmentation. Med Image Anal. 2009 Feb; 13(1):156-66.
    View in: PubMed
    Score: 0.004
  51. An imaging workflow for characterizing phenotypical change in large histological mouse model datasets. J Biomed Inform. 2008 Dec; 41(6):863-73.
    View in: PubMed
    Score: 0.004
  52. Identification of novel posttranscriptional targets of the BCR/ABL oncoprotein by ribonomics: requirement of E2F3 for BCR/ABL leukemogenesis. Blood. 2008 Jan 15; 111(2):816-28.
    View in: PubMed
    Score: 0.004
  53. Detection and visualization of surface-pockets to enable phenotyping studies. IEEE Trans Med Imaging. 2007 Sep; 26(9):1283-90.
    View in: PubMed
    Score: 0.004
  54. Rb-mediated neuronal differentiation through cell-cycle-independent regulation of E2f3a. PLoS Biol. 2007 Jul; 5(7):e179.
    View in: PubMed
    Score: 0.004
  55. Unique requirement for Rb/E2F3 in neuronal migration: evidence for cell cycle-independent functions. Mol Cell Biol. 2007 Jul; 27(13):4825-43.
    View in: PubMed
    Score: 0.004
  56. Hypermethylation of GpG islands in the promoter region of p15(INK4b) in acute promyelocytic leukemia represses p15(INK4b) expression and correlates with poor prognosis. Leukemia. 2003 May; 17(5):919-24.
    View in: PubMed
    Score: 0.003
  57. Structural characterization of Rasgrf1 and a novel linked imprinted locus. Gene. 2002 May 29; 291(1-2):287-97.
    View in: PubMed
    Score: 0.003
  58. Expression of the c-met proto-oncogene and its ligand, hepatocyte growth factor, in Hodgkin disease. Blood. 2001 Feb 15; 97(4):1063-9.
    View in: PubMed
    Score: 0.002
  59. High cyclin-dependent kinase inhibitors in Bcl-2 and Bcl-xL-expressing CD34+-proliferating haematopoietic progenitors. Br J Haematol. 2000 Sep; 110(3):654-62.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.